Trial Details

RECRUITING
Basic Information
Clinical ID c612
Identifier NCT06067698
Trial Title Alpha Lipoic Acid in Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis|Ulcerative Colitis (UC)
Interventions DRUG: Mesalamine and alpha-lipoic acid|DRUG: Mesalamine and Placebo
Participant Information
Sponsor Tanta University
City Tanta
Country/Region Egypt
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase -
Time Information
Start Date 2023-10-01
Primary Completion Date 2025-04-01
Completion Date 2025-04-01